UPDATE : Monday, October 15, 2018
상단여백
Hanmi’s US partner will test more to confirm NSCLC treatment’s efficacy
Hanmi Pharmaceutical said Thursday that Spectrum, Hanmi’s U.S. partner, wil...
by Lee Han-soo  |  2018-09-13 14:37
라인
Female workforce scarce in top 15 local pharmaceuticals
Among the top 15 domestic drug companies, Kwangdong Pharmaceutical has the ...
by Nam Doo-hyun  |  2018-09-13 11:41
라인
‘Metastatic ovarian cancer has different mutations from primary cause’
Researchers at Seoul National University Hospital (SNUH) have discovered th...
by Lee Han-soo  |  2018-09-12 16:37
라인
GC Cell shares spike on winning FDA nod for Immuncell-LC
Stock prices of GC Cell and ToolGen went in the opposite direction on Wedne...
by Nam Doo-hyun  |  2018-09-12 16:05
라인
Access Bio gets WHO prequalification approval for Ethiopian plant
Access Bio announced on Wednesday that it has obtained prequalification (PQ...
by Lee Han-soo  |  2018-09-12 15:01
라인
GC MS breaks ground for new local plant
GC MS, previously known as Green Cross MS, announced Wednesday that constru...
by Lee Han-soo  |  2018-09-12 14:58
라인
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’
The biotech industry is paying close attention to how the recent controvers...
by So Jae-hyeon  |  2018-09-12 14:25
라인
‘Xgeva reduces risk of bone problems in solid tumor patients’
Amgen Korea’s Xgeva (ingredient: denosumab), a therapy for bone metastases ...
by Nam Doo-hyun  |  2018-09-12 12:23
라인
ABL Bio, Yuhan sign cooperative agreement
ABL Bio said Monday that it has signed a license-out and cooperative agreem...
by Lee Han-soo  |  2018-09-11 16:54
라인
Shire’s SBS treatment to bring new hope to pediatric patients
Gattex (ingredient name: Teduglutide), Shire’s short bowel syndrome (SBS) t...
by Lee Han-soo  |  2018-09-11 16:17
라인
Hepatitis C patients wait for Maviret’s arrival
Korean physicians and patients have expressed high expectations for AbbVie ...
by Nam Doo-hyun  |  2018-09-11 16:16
라인
Korean hospitals no more vulnerable to MERS
Korean hospitals have entered into a high alert mode as the authorities rec...
by Song Soo-youn  |  2018-09-11 14:06
라인
Medpecto to test immunotherapy combo with MSD
Medpacto, a subsidiary of Theragen ETEX, said Tuesday that the Ministry of ...
by Lee Han-soo  |  2018-09-11 13:04
라인
Wonkwang University Hospital to continue cooperation with US army
Wonkwang University Hospital (WUH) and the Eighth U.S. Army (EUSA) in Gunsa...
by Lee Han-soo  |  2018-09-11 10:54
라인
Astellas wins nod for phase-3 trial on gastric cancer treatment
Astellas has obtained the regulatory approval to go ahead with a global pha...
by Lee Hye-seon  |  2018-09-11 10:38
라인
MERS infection affects stock market
Pharmaceuticals and biotech businesses are gathering renewed attention afte...
by So Jae-hyeon  |  2018-09-10 16:25
라인
Doctors call for tighter quarantine control over MERS case
Korea’s medical community urged the government to prepare measures to fix t...
by Choi Gwang-seok  |  2018-09-10 15:40
라인
‘ToolGen’s KOSDAQ listing might be in peril’
ToolGen, a local biotech firm specialized in gene editing, has been mired i...
by Nam Doo-hyun  |  2018-09-10 14:59
라인
Major hospitals successfully contain Korea’s 1st MERS case in 3 years
The so-called big-five hospitals have successfully managed to contain the M...
by Lee Han-soo  |  2018-09-10 14:25
라인
Kwangdong licenses Canadian company’s nonsteroidal anti-inflammatory drug candidate
Kwangdong Pharmaceutical said Monday that it has signed a licensing agreeme...
by Lee Han-soo  |  2018-09-10 14:23
여백
여백
여백
Back to Top